Chicago, IL -- (SBWIRE) -- 02/21/2017 -- According to the new market research report, "Active Pharmaceutical Ingredient (API) Market, by Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Classification (HPAPI, Others), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", published by Scalar Market Research, the global active pharmaceutical ingredient (API) market is expected to grow at a steady CAGR of 6.4% and reach USD 224.63 billion by the year 2022.

The global active pharmaceutical ingredient (API)market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium insights, technology trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.

Browse Report Summary: https://www.scalarmarketresearch.com/market-reports/active-pharmaceutical-ingredients-api-market

Early buyers will receive 10% free customization on this report.

Key findings of the report:

-According to the report, the rapid advancements in biologicsare one of the major driving factors for the global active pharmaceutical ingredient (API) market.

-Apart from that, the rising local manufacturing and the growth in the number of aging population are also expected to drive the global active pharmaceutical ingredient (API) market during the forecast period.

-The increasing awareness towards generic drugs and the growing government initiatives are also expected to boost the growth of the active pharmaceutical ingredients (API) market during the forecast period.

Detailed segmentation analysis of the active pharmaceutical ingredient (API) market

The report segments the global active pharmaceutical ingredient (API) market by manufacturers, synthesis, drug types, classifications, therapeutic areas, and geographic regions. The manufacturer segments are further divided into merchant and captive. The synthesis segment includes biological and synthetic. The drug types include generic and branded. The classifications include HPAPI and others. The therapeutic areas include metabolic disorders, cardiovascular diseases, NSAIDs, CNS, musculoskeletal diseases, oncology, and others. Based on the geographic regions, the global active pharmaceutical ingredient (API) market is further divided into North America, Asia-Pacific, Europe, and Rest of the World.

Request Sample: https://www.scalarmarketresearch.com/request-sample.php?id=30

Key Topics Covered:
-Market Overview
-Executive Summary
-Market Dynamics
-Industry Analysis
-Active Pharmaceutical Ingredient (API) Market, By Manufacturer
-Active Pharmaceutical Ingredient (API) Market, By Synthesis
Active Pharmaceutical Ingredient (API) Market, By Drug Type
-Active Pharmaceutical Ingredient (API) Market, By Classification
-Active Pharmaceutical Ingredient (API) Market, By Therapeutic Area
-Active Pharmaceutical Ingredient (API) Market, By Regions
-Competitive Landscape

-Key Market Players
-Teva Pharmaceutical Industries, Ltd
-Sun Pharmaceutical Industries Ltd
-Dr.Reddy's Laboratories
-AurobindoPharma Ltd
-Mylan N.V
-Novartis AG
-Cambrex Corporation
-BoehringerIngelheim GmbH
-Pfizer, Inc
-Lonza Group

Browse Related Reports:
API Contract Manufacturing Market, by Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

https://www.scalarmarketresearch.com/market-reports/api-contract-manufacturing-market

Molecular Diagnostics Market, by Products (Reagents, Consumables, Instruments, Systems), Technologies (PCR, INAAT, Microarrays, Immunochemical, Sequencing), Applications (Infectious Diseases, Oncology, Genetic Testing, Blood Screening, Microbiology) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

https://www.scalarmarketresearch.com/market-reports/molecular-diagnostics-market

About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S.-based market research and consulting firm that serves Fortune 1000 companies, leading businesses and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.

Scalar Market Research is a portfolio company of ALCOR GROUP, a Chicago, U.S.-based Mergers & Acquisitions giant with immense experience and connection with more than 1500 global funds which include leading Angel, VC, PE, Hedge, LBO, and Buyout Funds. ALCOR also deals in other services including Fund & Asset Management, Private Equity, and Corporate Finance. Our strong connection with the ALCOR GROUP of companies gives us an extra edge in delivering unique business intelligence.

Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degree perspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of global markets and cumulative industry experience spanning 100+ years, works relentlessly to help our clients realize their most important business goals.

Find out more about our services at:www.scalarmarketresearch.com

Contact:
Moses Nakka
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: 800-213-5170 (U.S./Canada Toll-free)
Email:sales@scalarmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/scalar-market-research